MOORE JOHN A 4

What Happened

John A. Moore, Chairman of the Board and a director of Scientific Industries, reported grants of derivative awards on 2026-02-17: options covering 230,000 shares and 30,000 shares (total 260,000). The filing lists a $0.00 price for these entries and shows the awards were granted in lieu of cash compensation. These were awards of options (derivative grants), not open-market purchases or sales, so no shares were sold and no cash changed hands at grant.

Key Details

• Transaction date(s): 2026-02-17 (reported as Form 4 filed 2026-03-17).
• Transaction type/code: A = Award/Grant (derivative option awards).
• Shares/options granted: 230,000 and 30,000 (total 260,000).
• Reported price: $0.00 for the grant entries in the Form 4.
• Vesting: Per footnote, the options vest over one year — 1/12th vest each month.
• Shares owned after transaction: These option grants do not immediately convert to common shares; the filing excerpt provided does not state a change in beneficially owned common stock.
• Timeliness: The Form 4 was filed 2026-03-17 for a 2026-02-17 transaction, which is later than the standard 2-business-day filing requirement.

Context

These entries represent option awards granted as director compensation rather than a cash purchase or sale. Derivative grants like this typically vest over time and must be exercised (and possibly taxed) before they become common shares you can trade. Awards to directors are common and do not by themselves indicate the director bought or sold existing shares in the market.